Moderna Pharmaceuticals
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
COVID-19 vaccine may come, but what about equitable distribution?
With rich countries and big pharma companies getting proactive, there is widespread apprehension about access and price of the vaccine for countries that need it most.
Vaccines will be the true game changers, says Dr. Satyajit Rath
Dr. Satyajit Rath talks about how vaccines are essential to turn the tide against the COVID-19 pandemic
COVID-19 and the race for the vaccine
Newsclick’s Prabir Purkayastha and Dr. Satyajit Rath discuss the latest in the research to develop the vaccine for COVID-19.
